Small proline-rich proteins 2 are noncoordinately upregulated by IL-6/STAT3 signaling after bile duct ligation

Laboratory Investigation

Volumn 85, Issue 1, 2005, Pages 109-123

  Nozaki, Isao ^a   Lunz III, John G ^a   Specht, Susan ^a   Stolz, Donna B ^b   Taguchi, Kenichi ^a   Subbotin, Vladimir M ^c   Murase, Noriko ^a   Demetris, Anthony J ^a,d  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Mirus Bio Corporation   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Biliary; Epithelia; Epithelial mesenchymal transition; Interleukin 6; Small proline rich proteins

Indexed keywords

BILE PIGMENT; GLYCOPROTEIN GP 130; INTERLEUKIN 6; PROLINE; PROTEIN; SMALL PROLINE RICH PROTEIN 2; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE; BILE DUCT LIGATION; CELL MEMBRANE; CONTROLLED STUDY; CROSS LINKING; CYTOPLASM; EPITHELIUM CELL; GENE EXPRESSION; HEPATOBILIARY SYSTEM; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SKIN; SQUAMOUS CELL METAPLASIA;

ANIMALS; ANTIGENS, CD; BILE DUCTS; CELLS, CULTURED; COMMON BILE DUCT; CYTOKINE RECEPTOR GP130; DNA-BINDING PROTEINS; EPITHELIUM; INTERLEUKIN-6; LIGATION; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN PRECURSORS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; UP-REGULATION;

EID: 12344280433     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700213     Document Type: Article

References (47)

1. Marenholz I, Zirra M, Fischer DF, et al. Identification of human epidermal differentiation complex (EDC)-encoded genes by subtractive hybridization of entire YACs to a gridded keratinocyte cDNA library. Genome Res 2001;11:341-355.
2. Cabral A, Voskamp P, Cleton-Jansen AM, et al. Structural organization and regulation of the small proline-rich family of cornified envelope precursors suggest a role in adaptive barrier function. J Biol Chem 2001;276:19231-19237.
3. Patel S, Kartasova T, Segre JA. Mouse Sprr locus: a tandem array of coordinately regulated genes. Mamm Genome 2003;14:140-148.
4. Mischke D, Korge BP, Marenholz I, et al. Genes encoding structural proteins of epidermal cornification and S100 calcium-binding proteins form a gene complex ('epidermal differentiation complex') on human chromosome 1q21. J Invest Dermatol 1996;106:989-992.
5. Elder JT, Zhao X. Evidence for local control of gene expression in the epidermal differentiation complex. Exp Dermatol 2002;11:406-412.
6. Gibbs S, Ponec M. Intrinsic regulation of differentiation markers in human epidermis, hard palate and buccal mucosa. Arch Oral Biol 2000;45:149-158.
7. Reddy SP, Konkin T, Wu R. Structure and organization of the genes encoding mouse small proline-rich proteins, mSPRR1A and 1B. Gene 1998;224:59-66.
8. Song HJ, Poy G, Darwiche N, et al. Mouse Sprr2 genes: a clustered family of genes showing differential expression in epithelial tissues. Genomics 1999;55:28-42.
9. Tarcsa E, Candi E, Kartasova T, et al. Structural and transglutaminase substrate properties of the small proline-rich 2 family of cornified cell envelope proteins. J Biol Chem 1998;273:23297-23303.
10. Stern LE, Erwin CR, Falcone RA, et al. cDNA microarray analysis of adapting bowel after intestinal resection. J Pediatr Surg 2001;36:190-195.
11. Hooper LV, Wong MH, Thelin A, et al. Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001;291:881-884.
12. Mueller A, O'Rourke J, Grimm J, et al. Distinct gene expression profiles characterize the histopathological stages of disease in Helicobacter-induced mucosa-associated lymphoid tissue lymphoma. Proc Natl Acad Sci USA 2003;100:1292-1297.
13. Tesfaigzi J, Carlson DM. Cell cycle-specific expression of G(0)SPR1 in Chinese hamster ovary cells. Exp Cell Res 1996;228:277-282.
14. Tan YF, Li FX, Piao YS, et al. Global gene profiling analysis of mouse uterus during the oestrous cycle. Reproduction 2003;126:171-182.
15. Robertson FG, Harris J, Naylor MJ, et al. Prostate development and carcinogenesis in prolactin receptor knockout mice. Endocrinology 2003;144:3196-3205.
16. Bonilla IE, Tanabe K, Strittmatter SM. Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J Neurosci 2002;22:1303-1315.
17. Liu Z, Sakamoto T, Ezure T, et al. Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: interactions between the periductal inflammatory and stromal cells and the biliary epithelium. Hepatology 1998;28:1260-1268.
18. Liu Z, Sakamoto T, Yokomuro S, et al. Acute obstructive cholangiopathy in interleukin-6 deficient mice: compensation by leukemia inhibitory factor (LIF) suggests importance of gp-130 signaling in the ductular reaction. Liver 2000;20:114-124.
19. Rosen HR, Winkle PJ, Kendall BJ, et al. Biliary interleukin-6 and tumor necrosis factor-alpha in patients undergoing endoscopic retrograde cholangiopancreatography. Dig Dis Sci 1997;42:1290-1294.
20. Scotte M, Daveau M, Hiron M, et al. Interleukin-6 (IL-6) and acute-phase proteins in rats with biliary sepsis. Eur Cytokine Networks 1991;2:177-182.
21. Kimmings AN, van Deventer SJ, Obertop H, et al. Endotoxin, cytokines, and endotoxin binding proteins in obstructive jaundice and after preoperative biliary drainage. Gut 2000;46:725-731.
22. Yasoshima M, Kono N, Sugawara H, et al. Increased expression of interleukin-6 and tumor necrosis factor-alpha in pathologic biliary epithelial cells: in situ and culture study. Lab Invest 1998;78:89-100.
23. Akiyama T, Hasegawa T, Sejima T, et al. Serum and bile interleukin 6 after percutaneous transhepatic cholangio-drainage. Hepatogastroenterology 1998;45:665-671.
24. Demetris AJ, Lunz JG, Subbotin V, et al. Participation of cytokines and growth factors in biliary epithelial proliferation and mito-inhibition during ductular reactions. In: Alpini G et al (eds). The Pathophysiology of the Biliary Epithelia. Landes Bioscience: Georgetown, TX, 2003, pp 167-191.
25. Ezure T, Sakamoto T, Tsuji H, et al. The development and compensation of biliary cirrhosis in interleukin-6-deficient mice. Am J Pathol 2000;156:1627-1639.
26. Nozaki I, Lunz J, Specht S, et al. Trefoil factor family 3 expression and function in the biliary tree. Am J Pathol 2004;Dec (in press).
27. Poli V, Balena R, Fattori E, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994;13:1189-1196.
28. Yokomuro S, Lunz JG, Sakamoto T, et al. The effect of interleukin-6 (IL-6)/gp130 signalling on biliary epithelial cell growth, in vitro. Cytokine 2000;12:727-730.
29. Yokomuro S, Tsuji H, Lunz III JG, et al. Growth control of human biliary epithelial cells by interleukin 6, hepatocyte growth factor, transforming growth factor beta1, and activin A: comparison of a cholangiocarcinoma cell line with primary cultures of non-neoplastic biliary epithelial cells. Hepatology 2000;32:26-35.
30. Park JI, Strock CJ, Ball DW, et al. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Mol Cell Biol 2003;23:543-554.
31. Skelly SM, Tackney C, Hicklin D, et al. High-level expression of a biologically active human interleukin-6 mutein. J Biotechnol 1994;34:79-86.
32. Ni R, Nishikawa Y, Carr BI. Cell growth inhibition by a novel vitamin K is associated with induction of protein tyrosine phosphorylation. J Biol Chem 1998;273:9906-9911.
33. Ishihara K, Hirano T. Molecular basis of the cell specificity of cytokine action. Biochim Biophys Acta 2002;1592:281-296.
34. Katou F, Shirai N, Kamakura S, et al. Differential expression of cornified cell envelope precursors in normal skin, intraorally transplanted skin and normal oral mucosa. Br J Dermatol 2003;148:898-905.
35. Dang Q, Gregersen H, Duch B, et al. Indicial response functions of growth and remodeling of common bile duct postobstruction. Am J Physiol Gastrointest Liver Physiol 2004;286:G420-G427.
36. Demetris AJ, Sakamoto T, Liu Z, et al. The ductular reaction in liver disease emphasis on a type I response. In: Fleig WE (ed). Normal and Malignant Liver Cell Growth. Kluwer Academic Publishers: Dordecht, 1999, pp 141-155.
37. Angelico M, De Sanctis SC, Gandin C, et al. Spontaneous formation of pigmentary precipitates in bile salt-depleted rat bile and its prevention by micelle-forming bile salts. Gastroenterology 1990;98:444-453.
38. Denson LA, Bohan A, Held MA, et al. Organ-specific alterations in RAR alpha:RXR alpha abundance regulate rat Mrp2 (Abcc2) expression in obstructive cholestasis. Gastroenterology 2002;123:599-607.
39. Hashmonai M, Kam I, Schramek A. The etiology of 'white bile' in the biliary tree. J Surg Res 1984;37:479-486.
40. Ahuja V, Garg PK, Kumar D, et al. Presence of white bile associated with lower survival in malignant biliary obstruction. Gastrointest Endosc 2002;55:186-191.
41. Birchmeier C, Birchmeier W, Gherardi E, et al. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 2003;4:915-925.
42. Richards TG, Thomson JY. The secretion of bile against pressure. Gastroenterology 1961;40:705-707.
43. Barber-Riley G. Rat biliary tree during short periods of obstruction of common duct. Am J Physiol 1963;205:1127-1131.
44. Ostrow JD. Biliary resorption of C14 bilirubin. J Lab Clin Med 1963;62:998-999.
45. Kalinin AE, Kajava AV, Steinert PM. Epithelial barrier function: assembly and structural features of the cornified cell envelope. Bioessays 2002;24:789-800.
46. Lin ZQ, Kondo T, Ishida Y, et al. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol 2003;73:713-721.
47. Ernst M, Inglese M, Waring P, et al. Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med 2001;194:189-203.